Site içinde arama yapın

Mahesh21 bir ses eklendi Other
2025-10-27 05:29:24 - Translate -

Acinetobacter Pneumonia Therapeutics Market to Reach USD 1.14 Billion by 2033, Growing at 5.8% CAGR
Acinetobacter Pneumonia Therapeutics Market Overview The global Acinetobacter pneumonia therapeutics market size was valued at USD 0.69 Billion in 2024 and is anticipated to grow from USD 0.73 Billion in 2025 to reach USD 1.14 Billion by 2033, exhibiting a CAGR of 5.8% during the forecast period (2025–2033). The rising prevalence of the...

0 Yorumlar 0 hisse senetleri 649 Views

Please log in to like, share and comment!
Mahesh21 bir ses eklendi Other
2025-11-04 10:30:30 - Translate -

CNS Therapeutics Market to Reach USD 243.6 Billion by 2033, Growing at 6.6% CAGR
Market Overview The global CNS therapeutics market size was valued at USD 137.04 Billion in 2024 and is expected to grow from USD 146.09 Billion in 2025 to reach USD 243.6 Billion by 2033, exhibiting a CAGR of 6.6% during the forecast period (2025–2033). The global CNS Therapeutics market continues to evolve rapidly, driven by shifting consumer trends,...

0 Yorumlar 0 hisse senetleri 502 Views

Please log in to like, share and comment!
Mahesh21 bir ses eklendi Health
2025-10-29 08:40:41 - Translate -

Global Scleroderma Therapeutics Market to Reach USD 3.83 Billion by 2033, Growing at a CAGR of 4.03%
Scleroderma Therapeutics Market Overview The global scleroderma therapeutics market size was valued at USD 2.66 billion in 2024 and is projected to grow from USD 2.79 billion in 2025 to reach USD 3.83 billion by 2033, exhibiting a CAGR of 4.03% during the forecast period (2025-2033). Download Exclusive Research Report PDF Sample: (Including Full TOC, List of...

0 Yorumlar 0 hisse senetleri 462 Views

Please log in to like, share and comment!
Mahesh21 bir ses eklendi Health
2025-11-11 05:46:16 - Translate -

Hepatitis B Therapeutics Market to Reach $5.94 Billion by 2033 — Growing at 3.65% CAGR
Market Overview The global hepatitis b therapeutics market size was valued at USD 4.3 billion in 2024 and is projected to reach from USD 4.46 billion in 2025 to USD 5.94 billion by 2033, growing at a CAGR of 3.65% during the forecast period (2025-2033). The global Hepatitis B Therapeutics market continues to evolve rapidly,...

0 Yorumlar 0 hisse senetleri 315 Views

Please log in to like, share and comment!